Osteoporosis Canada (OC) is pleased to announce the updated version of “Key performance indicators (KPIs) for Canadian FLSs (v2.0)”. Version 2 of the OC FLS KPIs brings in new learnings […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Prepared and reviewed by members of the Scientific Advisory Council of Osteoporosis Canada – Updated August 6, 2013 Calcitonin is a hormone found naturally in our bodies. A synthetic form […]

Recruitment Recruitment Are you a researcher? Osteoporosis Canada will provide support for the recruitment of participants for ethical and reputable research relevant to Osteoporosis Canada’s vision and mission. Interested in […]

Great Giving Challenge You Could Win $20,000 for Osteoporosis Canada! The Great Canadian Giving Challenge is a month-long initiative to help us raise much needed funds to support the over […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

How to Minimize the Harmful Effects Of Medications And Other Medical Conditions On Bone Talk To Your Doctor If you are taking any medications or suffer from any medical conditions […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Members of Osteoporosis Canada’s Scientific Advisory Council would like announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. Osteoporosis Canada established this award in 1993 […]